Usana Health Sciences (USNA) Gains from Investment Securities (2016 - 2026)
Usana Health Sciences (USNA) has disclosed Gains from Investment Securities for 16 consecutive years, with $56000.0 as the latest value for Q1 2026.
- Quarterly Gains from Investment Securities changed N/A to $56000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Jan 2026, up 234800.0% year-over-year, with the annual reading at $2.3 million for FY2026, 234800.0% up from the prior year.
- Gains from Investment Securities for Q1 2026 was $56000.0 at Usana Health Sciences, down from $100000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $4.8 million in Q4 2022, with the low at -$4.6 million in Q4 2022.
- Average Gains from Investment Securities over 5 years is $315000.0, with a median of $40000.0 recorded in 2025.
- Peak annual rise in Gains from Investment Securities hit 95266.67% in 2023, while the deepest fall reached 163.18% in 2023.
- Over 5 years, Gains from Investment Securities stood at $4.8 million in 2022, then crashed by 161.27% to -$3.0 million in 2023, then skyrocketed by 100.54% to $16000.0 in 2024, then surged by 525.0% to $100000.0 in 2025, then plummeted by 44.0% to $56000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at $56000.0, $100000.0, and $24000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.